Pfizer: Bearish Catalysts Brewing

KM Capital
5.44K Followers
(8min)

Summary

  • Pfizer's 7.45% forward dividend yield is misleading, as the share price decline outpaces the payout.
  • Weak dividend growth, stagnant EPS projections, and a looming patent cliff are significant bearish catalysts for Pfizer.
  • Regulatory hurdles and bearish technical indicators further reinforce the negative outlook for Pfizer's stock.
  • Despite some bullish analyst ratings, the 6% upside potential does not justify the risks associated with Pfizer's deteriorating fundamentals.
Corporate Headquarters of Pfizer Pharamcueticals in Midtown Manhattan

ChainGangPictures

Introduction

Pfizer's (NYSE:PFE) stock continued suffering over the last three months, which reinforces my bearish outlook I discussed in February. Despite the recent share price pullback, I am still confident that PFE remains a 'Strong sell'. The reason behind it is

This article was written by

5.44K Followers
Coming from an IT background, I have dived into the U.S. stock market seven years ago by managing portfolio of my family. Starting managing real money has been challenging for the first time, but long hours of mastering fundamental analysis of public companies paid off and now I feel very confident in my investment decisions. My hands-on experience shaped deep understanding of risk, reward and the delicate balance between these two variables. Driven by a desire to share my insights and contribute to the investor community, I embark on this new chapter with Seeking Alpha. My articles will be crafted with clarity and precision, devoid of jargon and fostering accessibility for investors of all experience levels. My background in IT grants me a valuable perspective, particularly when navigating the complexities of technology stocks. Yet, my pursuit of knowledge extends beyond the realm of silicon, encompassing diverse sectors and uncovering promising prospects across the economic landscape. Whether you are a seasoned investor seeking fresh perspectives or a nascent one embarking on your financial voyage, I extend a warm invitation to join me on this intellectual journey. Through collaborative exploration and insightful analysis, let us unlock the secrets of the market and chart a path towards shared financial success.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About PFE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on PFE

Related Stocks

SymbolLast Price% Chg
PFE
--
PFE:CA
--